Anastrozole Tablets 1 mg IP

Anastrozole Tablets are a prescription aromatase inhibitor used in the treatment of hormone-receptor-positive breast cancer in postmenopausal women. The active ingredient, anastrozole, works by blocking the aromatase enzyme and thereby reducing the amount of estrogen the body produces. Because a proportion of breast tumours require estrogen to grow, lowering circulating estrogen helps slow or stop the growth of these cancer cells. The tablets are supplied as white to off-white, round film-coated tablets in strip packaging, and are intended for use under the supervision of a qualified oncologist.

Therapeutic Use and Clinical Applications

Anastrozole is indicated as adjuvant treatment of early hormone-receptor-positive invasive breast cancer in postmenopausal women, as first-line treatment of locally advanced or metastatic breast cancer in postmenopausal women, and as treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy. In each setting the objective is sustained suppression of estrogen production, which is the driver of tumour growth in hormone-sensitive disease. Dosing is one tablet once daily, taken at the same time each day, with or without food, and treatment duration is determined by the treating physician.

Presentation, Packing and Shelf Life

The product is supplied at a strength of 1 mg per tablet in strip packaging, with each pack containing 2 strips of 14 tablets. Tablets are white to off-white, round and film-coated for consistent dosing. Shelf life is 24 months from the date of manufacture when stored in the original sealed packaging. Every consignment is dispatched with a certificate of analysis and material safety data sheet.

Storage and Handling

Store in a cool, dry place below 30 degrees Celsius, protected from direct light and moisture. Keep the strips in the outer carton until use. This is a prescription-only medicine and must be handled, stored and dispensed in accordance with local regulatory requirements.

Frequently Asked Questions

Q: What is the active ingredient in these tablets?

A: The active ingredient is anastrozole, presented at a strength of 1 mg per tablet.

Q: How do these tablets work?

A: Anastrozole is an aromatase inhibitor. It reduces the level of estrogen in the body, which helps slow down the growth of breast tumours that require estrogen to grow.

Q: How should these tablets be stored?

A: Store in a cool, dry place below 30 degrees Celsius, away from direct light and moisture.

Q: What is the shelf life?

A: The shelf life is 24 months from the date of manufacture when stored in the original sealed packaging.

Q: What is the minimum order quantity and lead time?

A: The minimum order quantity is 100 units, with a standard lead time of 2 to 3 weeks from order confirmation.

Q: Do you supply documentation with the consignment?

A: Yes. A certificate of analysis and material safety data sheet are supplied with every consignment, and additional regulatory documentation can be provided on request.